Alberto Bosque
Overview
Explore the profile of Alberto Bosque including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
2825
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Howard J, Levinger C, Deletsu S, Fromentin R, Chomont N, Bosque A
PLoS Pathog
. 2024 Oct;
20(10):e1012601.
PMID: 39401241
Development of novel therapeutic strategies that reactivate latent HIV and sensitize reactivated cells to apoptosis is crucial towards elimination of the latent viral reservoir. Among the clinically relevant latency reversing...
2.
Howard J, Zaikos T, Levinger C, Rivera E, McMahon E, Holmberg C, et al.
JCI Insight
. 2024 Aug;
9(18).
PMID: 39115957
Nonreceptor tyrosine phosphatases (NTPs) play an important role in regulating protein phosphorylation and have been proposed as attractive therapeutic targets for cancer and metabolic diseases. We have previously identified that...
3.
Holmberg C, Levinger C, Abongwa M, Ceriani C, Archin N, Siegel M, et al.
JCI Insight
. 2024 Jul;
9(17).
PMID: 39078714
The role of different biological variables including biological sex, age, and sex hormones in Human immunodeficiency virus (HIV) cure approaches is not well understood. The γc-cytokine IL-15 is a clinically...
4.
Levinger C, Howard J, Bosque A
Methods Mol Biol
. 2024 May;
2807:343-354.
PMID: 38743239
Assays to study HIV persistence are crucial to evaluate therapeutic strategies aimed toward an HIV cure. Several assays have been developed to date that rely on the measurement of nucleic...
5.
6.
Cobos Jimenez V, Geretz A, Tokarev A, Ehrenberg P, Deletsu S, Machmach K, et al.
iScience
. 2023 Oct;
26(10):108015.
PMID: 37860759
Persistent HIV-1 reservoirs of infected CD4 T cells are a major barrier to HIV-1 cure, although the mechanisms by which they are established and maintained remain poorly characterized. To elucidate...
7.
Howard J, Bosque A
Viruses
. 2023 Sep;
15(9).
PMID: 37766318
In spite of the advances in antiretroviral therapy to treat HIV infection, the presence of a latent reservoir of HIV-infected cells represents the largest barrier towards finding a cure. Among...
8.
Sanz M, Weideman A, Ward A, Clohosey M, Garcia-Recio S, Selitsky S, et al.
Front Immunol
. 2023 Sep;
14:1219250.
PMID: 37744358
Antiretroviral therapy (ART) is not curative due to the existence of cellular reservoirs of latent HIV-1 that persist during therapy. Current research efforts to cure HIV-1 infection include "shock and...
9.
Copertino Jr D, Holmberg C, Weiler J, Ward A, Howard J, Levinger C, et al.
JCI Insight
. 2023 Aug;
8(18).
PMID: 37581929
IL-15 is under clinical investigation toward the goal of curing HIV infection because of its abilities to reverse HIV latency and enhance immune effector function. However, increased potency through combination...
10.
Sanz M, Mann B, Ryan P, Bosque A, Pennington D, Hackstein H, et al.
Front Immunol
. 2023 Apr;
14:1148988.
PMID: 37063856
Under non-pathological conditions, human γδ T cells represent a small fraction of CD3 T cells in peripheral blood (1-10%). They constitute a unique subset of T lymphocytes that recognize stress...